Thoracic Surgery (Cardiothoracic Vascular Surgery) Doctors in Annapolis, MD Accepting Medicare

4 Thoracic Surgery (Cardiothoracic Vascular Surgery) doctors found. Showing 1 - 4

Dr. David Myers, M.D., F.A.C.S. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Not Enrolled in Medicare Practice Location: 713 Childs Point Rd, Annapolis, MD 21401 Phone: 410-571-5724

Dr. Stephen Michael Cattaneo Ii, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 2003 Medical Pkwy, Suite 301, Annapolis, MD 21401 Phone: 443-481-3300

Dr. Karl Derivas Holschuh, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Not Enrolled in Medicare Practice Location: 2001 Medical Pkwy, 2nd Floor Donner Pavilion, Annapolis, MD 21401 Phone: 443-481-3300    Fax: 443-481-3315

Dr. Avedis Meneshian, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 2003 Medical Pkwy, Suite 301, Annapolis, MD 21401 Phone: 443-481-3300    Fax: 443-481-3315

News Archive

SARS-CoV-2 variants do not substantially affect CD4+ and CD8+ T cell responses, study shows

Researchers from California in the United States have conducted a study showing that important adaptive immune responses to infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are not affected by four recently emerged variants of the virus.

Trandolapril and verapamil reduce risk of developing diabetes in Hispanic patients

The combination of drugs traditionally used to control blood pressure might not be ideal for Hispanic patients, University of Florida researchers warn.

Researchers report high response rate with single drug in phase I/II trial of paediatric brain cancer

A high response rate with a single drug in a phase I/II trial of paediatric brain tumour has set the stage for combination therapy with higher response and lower toxicity, researchers reported at the ESMO 2016 Congress in Copenhagen.

Extreme morning sickness drug comes at a price

Women, who suffer from an extreme form of morning sickness called hyperemesis gravidarum (HG), are shelling out $7,000 for a drug not yet approved for use by expectant mums because they are desperate to control their illness. HG leads to severe nausea, dehydration and fatigue and may require hospitalization. It affects up to 3 per cent of pregnant women - about 9,000 per year in Australia. It may lead to termination of the pregnancy.

Read more Medical News

› Verified 5 days ago